Panel discussion at the RI-MUHC marks International Day of People Living with Disabilities
Experts and advocates joined the RI-MUHC community to discuss integrating people with disabilities into work...
RI-MUHC trainee wins best presentation award at the 2022 Congrès provincial de la recherche Mère-Enfant
Doctoral student Wajih Jawhar demonstrates that epigenetic...
Liquid biopsy research: a generous boost to help children with cancer
A Montreal research team, headed by the eminent Janusz Rak, MD, PhD, continues to lead the way to the “next frontier” in pediatric cancer screening, diagnosis...
Canada's Top 40 Research Hospitals: three years in the top 3!
Thanks to RI-MUHC researchers, trainees and staff, the MUHC maintains its leadership position in the Canadian research ecosystem
Triple-negative breast cancer: the RI-MUHC enrolls first patients in international Phase 3 clinical trial
The first participants in this large study were recently selected at the Cedars Cancer Centre of the MUHC.
Dr. Carolyn Freeman named to Order of Canada
A passion to change the lives of cancer patients, young and old
Researchers discover how brain cells may be hardwired for vulnerability to deadly childhood brain tumour
A clearer understanding of how brain tumours originate during brain development is paving the way for improved therapies against pediatric high-grade gliomas, the leading cause of cancer-related deaths in children and young adults.
Happy first anniversary to the Quebec SmartCare Consortium!
Led by the Opal group at the RI-MUHC, the consortium has already made advances in data infrastructure and governance, as well as improving...
$2 million USD to investigate new approaches for prostate cancer treatment
RI-MUHC researcher David P. Labbé and a team of international collaborators will investigate the mechanisms...
